Subject
Health Policy,Oncology,Internal Medicine
Reference25 articles.
1. Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England;Aziz;J Infect,2023
2. Risk of severe outcomes among Omicron sub-lineages BA.4.6, BA.2.75 and BQ.1 compared to BA.5 in England;Seghezzo;Epidemiology,2023
3. Notes from the field: epidemiologic characteristics of SARS-CoV-2 recombinant variant XBB.1.5 — New York City, November 1, 2022–January 4, 2023;Luoma;MMWR Morb Mortal Wkly Rep,2023
4. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants;Wang;Cell,2023
5. Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies;Planas;Nat Commun,2023
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献